SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo
収録刊行物
-
- J. Pharmacol. Exp Ther.
-
J. Pharmacol. Exp Ther. 287 705-, 1998